Checkpoint immunotherapy utilizing PD-1 blockade has become the standard of care for metastatic melanoma. While this treatment is effective in 40% of patients, the other 60% develop resistance, leading to tumor regrowth. A multidisciplinary research team led by the University of California, Irvine has identified a new strategy that could enhance the therapeutic effectiveness of this therapy by targeting the communication between immune cells within the tumor.
'A broader view': How science communication is taught across the UC dailybruin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailybruin.com Daily Mail and Mail on Sunday newspapers.
Circadian Clock Boosts Cancer Immunotherapy, UCI Study Finds miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Study reveals circadian clock can be leveraged to enhance cancer immunotherapy medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.